Max Robotics — Global Service Robot Directory + US Certification

About

Hideto Fujita is a leading figure in the surgical management of gastric and upper gastrointestinal cancers, with a career dedicated to refining minimally invasive techniques. His primary research focuses on precision surgery for early gastric cancer, particularly the critical balance between radical lymph-node dissection and organ preservation. Fujita’s seminal 2019 work on lymph-node metastasis in early gastric cancer, which has garnered 51 citations, established a framework for identifying node-negative patients preoperatively, enabling safer endoscopic and local resections. He has advanced the field of local stomach resection, exploring methods like laparoscopic lesion lifting and endoscopic full-thickness resection to minimize postoperative symptoms. More recently, Fujita has been at the forefront of robotic surgery, authoring a 2025 narrative review that highlights the transformative potential of robot-assisted systems in upper GI oncology. His clinical acumen is further demonstrated by a pioneering 2024 case report on the multidisciplinary treatment of a rare cervical esophageal adenocarcinoma derived from a gastric inlet patch. With a growing citation impact, Fujita’s work is shaping the future of tailored, less invasive surgical care for gastrointestinal cancer patients.